|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,117.15 MXN | -6.44% |
|
-6.44% | -4.73% |
| 06-16 | Gilead Sciences Insider Sold Shares Worth $376,200, According to a Recent SEC Filing | MT |
| 06-16 | Warsh Takes the Stage |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | Other Pharmaceuticals | -6.44% | -6.44% | -4.73% | +1.45% | +54.76% | 158B |
-
|
-
|
-
|
- Stock Market
- Stocks
- GILD Stock
- GILD * Stock
- Charts Gilead Sciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















